![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer
Publisher: Spandidos Publications
ISSN: 1021-335X
Source: Oncology Reports, Vol.27, Iss.3, 2012-01, pp. : 673-677
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)